iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Holdings Reduced by Arkansas Financial Group Inc.

Arkansas Financial Group Inc. lessened its holdings in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 20.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,923 shares of the company’s stock after selling 1,746 shares during the period. Arkansas Financial Group Inc. owned 0.07% of iShares U.S. Pharmaceuticals ETF worth $455,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in IHE. Mercer Global Advisors Inc. ADV raised its stake in iShares U.S. Pharmaceuticals ETF by 7.4% during the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 3,837 shares of the company’s stock valued at $254,000 after acquiring an additional 266 shares in the last quarter. Thrivent Financial for Lutherans raised its stake in shares of iShares U.S. Pharmaceuticals ETF by 9.5% during the second quarter. Thrivent Financial for Lutherans now owns 26,295 shares of the company’s stock valued at $1,744,000 after purchasing an additional 2,272 shares in the last quarter. Marshall Wace LLP bought a new stake in shares of iShares U.S. Pharmaceuticals ETF during the second quarter valued at about $422,000. Rockport Wealth LLC acquired a new stake in iShares U.S. Pharmaceuticals ETF in the second quarter worth about $12,091,000. Finally, SPC Financial Inc. bought a new position in iShares U.S. Pharmaceuticals ETF in the 3rd quarter valued at about $225,000.

iShares U.S. Pharmaceuticals ETF Trading Up 1.3 %

IHE stock opened at $67.59 on Friday. The firm’s 50-day moving average is $67.05 and its two-hundred day moving average is $69.00. The company has a market capitalization of $682.66 million, a price-to-earnings ratio of 6.49 and a beta of 0.58. iShares U.S. Pharmaceuticals ETF has a 52 week low of $62.67 and a 52 week high of $72.94.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.